Irritable Bowel Syndrome: all 1,084 studies

Page 11 of 11. Open to participants first (196), then studies with results posted, then the rest; newest registration first within each.

• Ondansetron for the Treatment of IBS With Diarrhoea (IBS-D)CompletedNCT00745004Phase 4
• Effects of the Soluble Mediators of Mastocytes on the Intestinal Epithelial Barrier and of the Enteric Nervous System During the Syndrome of the Irritable BowelCompletedNCT00742118Not applicable
• Web-Based Survey of Pain, Stress and Complementary and Alternative MedicineCompletedNCT00740233
• Effect of Bifidobacterium on Irritable Bowel SyndromeStatus unknownNCT00737841Not applicable
• The Effect of Serotonergic Modulation on Intestinal Permeability and Visceral Hypersensitivity in Healthy Individuals and Irritable Bowel Syndrome (IBS) PatientsCompletedNCT00731003Not applicable
• Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic NauseaCompletedNCT00728026
• Structured Patient Education Versus Written Information for Patients With Irritable Bowel SyndromeCompletedNCT00706758Not applicable
• The Effect of a Multispecies Probiotic on Hypersensitivity in Irritable Bowel Syndrome (IBS) PatientsCompletedNCT00702026Not applicable
• Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT00699166Phase 2
• Validation of Surrogate Measures in Irritable Bowel Syndrome (IBS)CompletedNCT00693732Phase 4
• Mindfulness vs. Support Groups for Irritable Bowel SyndromeCompletedNCT00680693Not applicable
• Use of Functional Magnetic Resonance Imaging (fMRI) to Study Brain Activation in Children With Irritable Bowel SyndromeCompletedNCT00677976
• The Efficacy of Tradition Chinese Medicine in Patients With Irritable Bowel SyndromeCompletedNCT00676975Phase 2
• Diagnostic Strategies in Patients Suspected of Irritable Bowel SyndromeCompletedNCT00659763
• Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice WorkflowCompletedNCT00634608Not applicable
• Mesalazine Therapy in Patients With Irritable Bowel SyndromeCompletedNCT00626288Phase 3
• Paroxetine - Controlled Release in the Treatment of Irritable Bowel Syndrome (IBS)CompletedNCT00610909Phase 4
• Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C)TerminatedNCT00607971Phase 3
• Saccharomyces Boulardii in Irritable Bowel SyndromeCompletedNCT00589771Phase 3
• SAT vs Escitalopram for Rectal HypersensitivityCompletedNCT00584571Phase 2
• Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using OctreotideCompletedNCT00584298Phase 1
• Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel SyndromeCompletedNCT00583128Phase 2
• Effect of a Probiotic, Lactobacillus FARCIMINIS, in Diarrhea Predominant IBS PatientsCompletedNCT00561535Phase 2
• Fructose Malabsorption in Northern NorwayCompletedNCT00555191Phase 2/3
• Effect of Repetitive Transcranial Direct Current Stimulation (tDCS) on Chronic Pelvic PainCompletedNCT00554320Not applicable
• Efficacy Study of Rezular (Arverapamil) in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)CompletedNCT00552565Phase 3
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in FemalesStatus unknownNCT00547469Phase 2/3
• Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel SyndromeStatus unknownNCT00543478Phase 4
• Efficacy and Safety of Meteospasmyl® in Irritable Bowel SyndromeCompletedNCT00542295Phase 4
• Recurrent Abdominal Pain in ChildrenCompletedNCT00526903Phase 2
• A Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic ConstipationNo longer availableNCT00511771
• A Study In Patients With Irritable Bowel Syndrome To Measure Hormone Response After Dosing With GW876008 And Gsk561679WithdrawnNCT00511563Phase 2
• A Study of 3 Doses of Dextofisopam in Females With Irritable Bowel SyndromeCompletedNCT00486876Phase 2
• A Computer-Based Intervention for Medically Unexplained Physical SymptomsCompletedNCT00468013Not applicable
• Diarrhea Predominant Irritable Bowel Syndrome in FemalesCompletedNCT00461526Phase 2
• Asimadoline for the Treatment of Subjects With Irritable Bowel SyndromeCompletedNCT00454688Phase 2
• Colon Investigation - Factors Determining Choice of ProcedureTerminatedNCT00423345
• Manipulation of Visceral Sensitivity and Immune System in IBSStatus unknownNCT00418340Phase 4
• A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy VolunteersCompletedNCT00401479Phase 1
• A Study of BMS-562086 in Patients With Irritable Bowel SyndromeCompletedNCT00399438Phase 2
• A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS)CompletedNCT00394186Phase 2
• Efficacy, Safety and Tolerability of DNK333 (25 mg Bid) in Women With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)CompletedNCT00394173Phase 2
• Effects Of GW876008 On The Bowel In Patients With Irritable Bowel SyndromeCompletedNCT00385099Phase 2
• Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy VolunteersCompletedNCT00376896Phase 1
• Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain DisordersCompletedNCT00374673Phase 3
• A Six-month Study to Compare Outcome Differences and Visceral Response ... Irritable Bowel SyndromeCompletedNCT00368771Not applicable
• The Effect of Probioticson Bloating in IBSStatus unknownNCT00368758Not applicable
• Probiotics for Irritable Bowel SyndromeCompletedNCT00355810Not applicable
• EFESO - EFficacy Enterogermina Small Intestinal Bacterial OvergrowthCompletedNCT00331994Phase 4
• Pilot Study to Assess the Effects of AV608 on Irritable Bowel SyndromeTerminatedNCT00316550Phase 1
• Effect of Butyrogenic Fibers in IBS PatientsStatus unknownNCT00314886Not applicable
• Evaluation of Patient Education in Irritable Bowel SyndromeCompletedNCT00305968Phase 3
• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel SyndromeCompletedNCT00269412Phase 2
• Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS)CompletedNCT00268879Phase 3
• Rifaximin for the Treatment of Irritable Bowel SyndromeCompletedNCT00259155Phase 2
• Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBSCompletedNCT00258193Phase 2
• 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBSCompletedNCT00230581Phase 2
• Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional PainStatus unknownNCT00222209Not applicable
• DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)CompletedNCT00220090Phase 3
• Effect of Menstrual Cycle on Central Nervous System (CNS) Processing of Gut Stimuli in Irritable Bowel Syndrome (IBS) and ControlTerminatedNCT00219531
• Effect of Acupuncture on Symptoms of Diarrhea and Pain in IBSTerminatedNCT00219505Not applicable
• A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of DDP733 for IBS-cCompletedNCT00215566Phase 2
• Cerebral Resonance Magnetic Imaging During Rectal DistentionWithdrawnNCT00213330
• Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS)CompletedNCT00194922Phase 2
• A Study of YM060 in Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189813Phase 2
• Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS)CompletedNCT00189696Phase 3
• Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre?CompletedNCT00189033Not applicable
• The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)TerminatedNCT00171431Phase 3
• Nursing Management of Irritable Bowel Syndrome:Improving OutcomesCompletedNCT00167635Phase 2/3
• Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBSCompletedNCT00142987Phase 4
• A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS.CompletedNCT00139672Phase 2
• Efficacy of an Encapsulated Probiotic Bifidobacterium Infantis 35624 in Irritable Bowel SyndromeCompletedNCT00135031Phase 3
• Combination Herbal Therapy (CHT) Versus Placebo in Patients With Irritable Bowel Syndrome (IBS)CompletedNCT00130741Phase 1
• Characterization of Pain Processing Mechanisms in Irritable Bowel SyndromeCompletedNCT00108446Phase 2
• Eight-Weeks Of Treatment With Talnetant In Subjects With Irritable Bowel Syndrome (IBS)CompletedNCT00101985Phase 2
• A Study of Crofelemer to Treat Diarrhea Irritable Bowel SyndromeCompletedNCT00101725Phase 2
• Characterization of Pain Processing Mechanisms in Irritable Bowel SyndromeCompletedNCT00100425Not applicable
• Acupuncture for Irritable Bowel Syndrome (IBS)CompletedNCT00093327Phase 2
• Genetics of FibromyalgiaStatus unknownNCT00071162
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067561Phase 3
• Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional TherapyCompletedNCT00067457Phase 3
• Brain Imaging and Pain in Irritable Bowel SyndromeCompletedNCT00065754Not applicable
• Acupuncture for Irritable Bowel SyndromeCompletedNCT00065403Phase 1/2
• Treatment of Functional Bowel DisordersCompletedNCT00006157Phase 3

← Irritable Bowel Syndrome overview